Bio-Rad Laboratories Inc (NYSE: BIO and BIOb) announced on Monday that it has appointed Dr Andrew Last as EVP and COO of the company, effective 22 April 2019.
In his new role, Dr Last will be is responsible for all operating functions of the company on a global basis.
Dr Last, who has over 30 years of global management experience, most recently served as chief commercial officer at Berkeley Lights Inc. Prior to that he was COO at Intrexon Corporation. Before that, from 2010 to 2016, he held senior roles at Affymetrix that included EVP and COO. Earlier he has held senior positions with Becton, Dickinson and Company, Applied Biosystems. Incyte Genomics and Monsanto Company.
Bio-Rad Laboratories develops, manufactures and markets a broad range of innovative products for the life science research and clinical diagnostic markets.
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval
Biocytogen and ABL Bio collaborate on development of new bispecific antibody-drug conjugates
BenevolentAI reports positive Phase Ia safety and pharmacokinetic data for BEN-8744
AstraZeneca announces US approval for Ultomiris for NMOSD treatment